Oral Scutellarin Treatment Ameliorates Retinal Thinning and Visual Deficits in Experimental Glaucoma

Purpose: Intraocular pressure (IOP) is currently the only modifiable risk factor for glaucoma, yet glaucoma can continue to progress despite controlled IOP. Thus, development of glaucoma neurotherapeutics remains an unmet need. Scutellarin is a flavonoid that can exert neuroprotective effects in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jingyuan, Sainulabdeen, Anoop, Akers, Krystal, Adi, Vishnu, Sims, Jeffrey R., Yarsky, Eva, Yan, Yi, Yu, Yu, Ishikawa, Hiroshi, Leung, Christopher K., Wollstein, Gadi, Schuman, Joel S., Wei, Wenbin, Chan, Kevin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369066/
https://www.ncbi.nlm.nih.gov/pubmed/34414202
http://dx.doi.org/10.3389/fmed.2021.681169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369066/
https://www.ncbi.nlm.nih.gov/pubmed/34414202
http://dx.doi.org/10.3389/fmed.2021.681169

Ejemplares similares